Prevalence and antimicrobial resistance profile of Staphylococcus aureus in inherited epidermolysis bullosa: a cross‐sectional multicenter study in Brazil
- 28 May 2021
- journal article
- research article
- Published by Wiley in International Journal of Dermatology
- Vol. 60 (9) , 1126-1130
Abstract
Background: Infection is an important complication of epidermolysis bullosa (EB), and Staphylococcus aureus has been pointed out as the most common pathogen among this population. The objective of this study was to investigate the prevalence and antimicrobial resistance profile of S. aureus colonizing EB patients in Brazil.Methods: This cross‐sectional multicenter study was conducted between December 2015 and December 2017. We included a total of 89 individuals with EB from medical centers across Brazil. Data were obtained through clinical and bacteriological investigation. S. aureus were identified by biochemical tests. The nuc and mecA genes were confirmed by PCR assay. Antimicrobial susceptibility was investigated by disk diffusion method.Results: The overall prevalence of S. aureus was 51.7% (46/89). Methicillin‐resistant S. aureus (MRSA) was detected in 24.7% (19/77) of all S. aureus isolates, colonizing 15.7% (14/89) of all patients. Community‐associated (CA)‐MRSA strains were resistant against sulfamethoxazole/trimethoprim and levofloxacin (P < 0.05%). S. aureus colonization of the nares and belly button represented a 3.4 times higher risk of simultaneous skin lesion colonization (P < 0.05%).Conclusions: The high frequency of MRSA colonizing patients with EB is alarming considering its association with life‐threatening complications and poorer outcomes. EB patients are at increased risk of colonization and infection by Staphylococcus aureus and CA‐MRSA. Getting to know S. aureus carriage sites and its antimicrobial susceptibility profile is key when planning new individualized and more effective prophylactic and therapeutic measures.Keywords
This publication has 38 references indexed in Scilit:
- Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragilityBritish Journal of Dermatology, 2020
- Inherited epidermolysis bullosa: New diagnostics and new clinical phenotypesExperimental Dermatology, 2018
- Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classificationJournal of the American Academy of Dermatology, 2014
- Inherited epidermolysis bullosa: clinical and therapeutic aspectsAnais Brasileiros de Dermatologia, 2013
- Inherited epidermolysis bullosaOrphanet Journal of Rare Diseases, 2010
- Inherited epidermolysis bullosa: past, present, and futureAnnals of the New York Academy of Sciences, 2010
- Extracutaneous manifestations and complications of inherited epidermolysis bullosaJournal of the American Academy of Dermatology, 2009
- The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EBJournal of the American Academy of Dermatology, 2008
- Cause-Specific Risks of Childhood Death in Inherited Epidermolysis BullosaThe Journal of Pediatrics, 2008
- Epidermolysis BullosaAmerican Journal of Clinical Dermatology, 2002